Skip to main navigation
Skip to content Larimar Therapeutics
Larimar Therapeutics Mobile Menu Toggle navigation
Larimar Therapeutics
  • About Larimar
    • Company Overview
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • Scientific Approach
    • Publications
  • Our Programs
    • Pipeline
    • CTI-1601
    • Expanded Access Policy
  • Our Partners
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Investor FAQs
    • Contact Us
    • Email Alerts
  • News
  • Contact
    • Contact Us
    • Directions
  • About Larimar
    • Company Overview
    • Leadership
    • Board of Directors
    • Careers
  • Our Science
    • Scientific Approach
    • Publications
  • Our Programs
    • Pipeline
    • CTI-1601
    • Expanded Access Policy
  • Our Partners
  • Investors
    • Investors
    • Press Releases
    • Events & Presentations
    • Corporate Governance
    • Financials & Filings
    • Stock Information
    • Investor FAQs
    • Contact Us
    • Email Alerts
  • News
  • Contact
    • Contact Us
    • Directions

Committee Composition

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
    • Upcoming events
    • Presentations
    • Past Events
  • FINANCIALS & FILINGS
    • SEC Filings
    • Annual Reports & Proxy Materials
    • Form 8937
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Investor FAQs
  • Contact Us
  • Email Alerts

Shareholder Tools

  • Email Alerts
  • RSS
  • Print
  • Share
 

  • Facebook
  • Google
  • LinkedIn
  • Twitter
  • Email
  • RSS

Investor Relations

  • Investors
  • Press Releases
  • Events & Presentations
    • Upcoming events
    • Presentations
    • Past Events
  • FINANCIALS & FILINGS
    • SEC Filings
    • Annual Reports & Proxy Materials
    • Form 8937
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Investor FAQs
  • Contact Us
  • Email Alerts

Committee Composition

Committee Composition

Audit Committee Compensation Committee Charter Nominating and Governance Committee
Peter Barrett, PhD Compensation Committee Charter Nominating and Governance Committee
Thomas O. Daniel, MD Nominating and Governance Committee
Tom Hamilton Audit Committee
Jonathan Leff Compensation Committee Charter Nominating and Governance Committee
Frank E. Thomas Audit Committee
Joe Truitt Audit Committee Compensation Committee Charter
= Chairperson = Member

© 2023 Larimar Therapeutics, Inc. All rights reserved.
LARIMAR and LARIMAR THERAPEUTICS are trademarks of Larimar Therapeutics, Inc.

Footer Nav

  • Terms of use
  • Privacy Policy
  • Site Credits